- Home
- GAUZ vs PLRX Comparison
GAUZ vs PLRX Comparison
Compare GAUZ & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAUZ
- PLRX
- Stock Information
- Founded
- GAUZ 2009
- PLRX 2015
- Country
- GAUZ Israel
- PLRX United States
- Employees
- GAUZ N/A
- PLRX N/A
- Industry
- GAUZ Industrial Machinery/Components
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- GAUZ Miscellaneous
- PLRX Health Care
- Exchange
- GAUZ Nasdaq
- PLRX Nasdaq
- Market Cap
- GAUZ 102.0M
- PLRX 93.3M
- IPO Year
- GAUZ 2024
- PLRX 2020
- Fundamental
- Price
- GAUZ N/A
- PLRX $1.51
- Analyst Decision
- GAUZ Strong Buy
- PLRX Hold
- Analyst Count
- GAUZ 3
- PLRX 10
- Target Price
- GAUZ $13.67
- PLRX $3.93
- AVG Volume (30 Days)
- GAUZ 44.2K
- PLRX 394.6K
- Earning Date
- GAUZ 11-11-2025
- PLRX 11-06-2025
- Dividend Yield
- GAUZ N/A
- PLRX N/A
- EPS Growth
- GAUZ N/A
- PLRX N/A
- EPS
- GAUZ N/A
- PLRX N/A
- Revenue
- GAUZ $96,810,000.00
- PLRX N/A
- Revenue This Year
- GAUZ $22.59
- PLRX N/A
- Revenue Next Year
- GAUZ $41.48
- PLRX N/A
- P/E Ratio
- GAUZ N/A
- PLRX N/A
- Revenue Growth
- GAUZ 7.87
- PLRX N/A
- 52 Week Low
- GAUZ $4.54
- PLRX $1.10
- 52 Week High
- GAUZ $13.00
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- GAUZ 62.21
- PLRX 48.98
- Support Level
- GAUZ $5.88
- PLRX $1.46
- Resistance Level
- GAUZ $6.80
- PLRX $1.55
- Average True Range (ATR)
- GAUZ 0.43
- PLRX 0.07
- MACD
- GAUZ 0.12
- PLRX 0.00
- Stochastic Oscillator
- GAUZ 100.00
- PLRX 65.52
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.